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times (DT; ms) of flow velocity in early dieetole and isovolumetric relaxation
time (IVRT; ins).
Resu/ts:Coronary angiography revealed significant CAD (coronarysteno-
sis >50’7. Iuminal dismeter in 28 Pta(15 male, 13 female) and no CAD in 15
pts (9 male, 8 female). Pts with CAD”demonstrated pathological alterations
of diastolic filling parameters: delayed ventricular relaxation (prolonged IVRT
(?106 mS),reduced E velocity and E/A ratio (<1.0) snd increaead DT (>288
ms) and a higher incidence of pathological criteria of exercise testing. In
males the diagnostic sensitivity and specifily of exercise testing (66%; 88Yo)
was comparable to eohocardiographic parameters (77%; 94%). In female pts
on the other hand the diagnostic sensitivity and specifity of exercise testing
(45%; 25%) was much Ioweranddiastolic perametera had a higherpredictive
value of CAD (sensitivity 98%; speoifity 97%).
Thus: Echccsrdiographic assessment of diastolic LV function represents
a valuable tool for the evaluation of suspected coronary artery disease in
women.
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Plaque Morphology Aaaessed by Intravascular
Ultrasound
N.J. Weissman, U.K. Arora, J.A. Breall, J.R. Gannuscio, D.J. Diver,
B.J. Gareh. Georgetown University Madkal Centec Washington,DC, USA
Pathologic studies suggest that gender differences in clinical presentation
may be due to variation in pfaque morphology. The purpose of this study
was to determine if there is indeed a gender difference in atherosclerotic
plaque morphology in-vivo. Methcds: Pr6-intewention intravascular ultra-
sound (IVUS) was performed in 106 pte (78 men, 30 women). Plaque nmr-
phology at the stenotic site and an adjacent non-stenotic site was classified
as calcified or non-calcified and plaque density was meaeuredby video den-
sitometry using a linear grey ecale normalized to adventitial density. Arterial,
plaque and Iuminal area were measured by planimetry. Results: Women un-
dergoing angiography had a similar degree of plaque burden (69.9+ 16.9%
vs 73.0* 13.3% C~SS-Sf3CfiOtMd flL3mOWiflg, p = nS), eccentricity (p = flS) and
Iuminal stenosis (p = ns) but were older (60.4 + 12.2 vs 55.0 + 10.9 yrs,
p < 0.05) than men. Despite the older age, the stenotic plaques in women
were lees dense (70.4 + 21.5% va 73.9 + 24.4% Qfadventitial density, p =
0.02) and less often calcified (20% vs 38%, p c 0.05). Likewise, plaques at
non-stenotic sites exhibitad a Iowar density in women (82.8 + 3.9% vs 97.1
+ 3.1% of adventitial density, p = 0.01). Conclusion: CoronaW plaques in
women are softer and less cslcified as compared to men. Sequential IVUS
exams would be necessary in an unselactal population to determine if the
lower incidence of fibrocalcific plaques in women isdueto initiation of plaque
development at an older age or slower plaque progression and to evaluate
the contribution made by altared plaque morphology to clinical presentation.
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Atherosclerosis Between Men and Women: An
Intravascular Ultrasound Study
R. Kornowski, G.S. Mintz, K.M. Kent, A.D. Pichard, L.F. Satler, J.J. Popma,
J.R. Leird, T.A. Bucher, A. Greenberg, A.J. Lensky,M.K. Kehoe, M.B. Leon.
Washington Hospital Center, Washington, DC, USA
We ueed pre-intefvention intravascular ultrasound {IVUS, measurement of
reference and lesion arterial, lumen, and piaqua area, cross-sectional nar-
rowing (CSN = plaque/atierial area), arc of calcium, and eccentricity (mex-
imumfminimum plaque thickness)} to determine whether differences exist
in de novo native coronary artery Iesione of men (n = 549, ages 60 + 11
yre) compared to women (n = 169, ages 66 + 11 yrs, p < 0.0001). All
IVUS cross-sectional area measurements were normelizedfor patient body
surface area:
Men Women o
Rsferencearterialarea(mmz)
Referencelumenarea(mm2)
Referenceplaquearea(mmz)
ReferenceCSN(%)
Referencearcofcelclum(0)
Lesionarterialarea(mm2)
Lesionlumenarea (mm2)
Lesionplaquearea (mmz)
LeeionCSN (%)
Lesionarxantricitv
9.2 + 6.8
4.7* 1.8
4.5 +6.1
49* 12
31 *64
S.7* 7.i
1,3 * 1.0
7.4*7.1
S5* 12
4.1 + 3.6
S.7k2.5
4.9 l 1.6
3.S& 1.6
47* 13
33* 69
6.3 %2,7
1.3 * 0,9
7.0&2.7
S5k 10
4.2*5.4
0.5555
0.3260
0.30s5
0.0566
0.6s12
0.5s36
0.s0s4
0.5667
0.721S
0.7713
intervention IVUS failed to detect qualitative (eccentricity, lesion or reference
calcification) or quantitative differences in coronary atherosclerosis in men
compared to women.
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to Myocardial Ischemia in Postmenopausal Women
with Coronary Artery Disease
C.M. Beale, G.M.C. Rosano, P.Collins. Netional Ffeart& Lung /nstitute,
Imperial College School of Medicine, end Royal Brompton Hospital,
London, UK
Acute administration of 17j+estradiol (Ez) improves mronary blood flow
and improves myocardial ischemia in postmenopausal women with coronary
artery dieease (CAD). The aim of the present study was to evaluate the effect
of chronic administration of Ez on exercise-induced myocardial iechaemia in
women with CAD. Twelve postmenopausal women (mean & SE; aged 65
+ 1 years) with angiographioelly proven CAD, who had not taken hormone
therapy within the previous 3 months, were included in the study. After
baseline exercise tasts patients were randomized, in a double-blind fashion,
to 50 Kg patch E2 (Evorel) or identical placebo (P) for4 weeks, followed by 4
weeks on 100 Kg E2. Patients then crossed over to the opposite treatment.
Exercise teeting and blood samples for analysie of plasma Ez level were
performed at 4, 8, 12 and 16 weeks, at the same hour of the day. Plasma
E2 levels were significantly increased after Ez at 4 and 8 weeks compared
to P (232 + 17 and 320+30 vs 95 + 21 and 51 + 11 pmol/1,respectively).
At 4 weeks there was a trend to an increase in exercise time to 1 mm ST
segment depression (559 + 52 vs 532 + 52 seconds, E2 vs P, respectively,
P = NS). However at 8 weeks’ treatment there waa a significant increase
in exercise time to 1 mm ST segment depression (561 + 58 vs 501 + 47
eaconds, Ez vs P,respectively, P= 0.04). In conclusion, chronic EZimproves
time to exercise-induced myocardial ischemia in pestmenopaueal women
with CAD. Exposure time to eetrogen may be important in the mechaniem of
this responee,
11:45
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Female Menopausal Patients with Syndrome X
G.M.C. Roeano, N.S. Paters, P.Collins, P.M.Sarrel, P.A. Pcde-Wilson.
Istituto H Sen Rar7ae/e,Mi/ano-Rome, Italy Nationa/Hearf& Lung Institute,
London, United Kingdom
SyndromeX(anginapactorie, ischemic-appearing exercise elaotro-csrdicgram,
normal coronary arteriograms) is more frequent in menopausal women than
in men. We have previously shown that hormone replacement therapy with
eetrediol-17b improvee chest pain in female menopausal patiente (pte) with
syndrome X. However, in order to prevent uterine and breast malignancies it
is recommended to give concurrent therapy with progestins to pts receiving
estrogen replacement therapy. We have investigated the effect of norethis-
terone aoetate (NEA) on chest pain in 25 menopausal women with syndrome
X. Pts were randomized to receive either 100 Kg estradiol-17p cutaneous
patchea (E) (12 pts) or placebo patches (P) (13 pts) for 10 weeks, in addition
to which they also received 10 mg of NEA daily during the last 2 weeks of the
treatment period. The number of episodes of chest pain during the final 10
days of each treatment phase was recorded. Pts had 8.1 + 6.7 episodes of
chest pairVIO daye during the first phase of the etudy (6.7 & 5.8 with P and
5.4 + 6 with E) mmpared to 8.7 + 9.9 episodesJIO days after the adjunct
of NEA (p = NS). No significant changee in the number of episodes of chest
pain/10 days were noted in patients allocated to P (6.7 + 5.6 vs 6.7 + 7, p =
NS) while a trend towards an incraased number of episodes of chest paird10
days was noted in th,osepta allocated to E (5.4 + 8 vs 10.8 + 12, p = 0.06).
One patient allocated to E discontinued the study because of worsening of
symptoms during the NEA phase.
Inconclusion NEAmayworean angina in female menopausal pts with syn-
drome X treated with estradiol 17B. This finding may support the hypothesis
that an hormonal imbalance may trigger syndrome X in female patients.
Lesionarc of calcium (Q) 9S* 104 97• too 0.s933
We conclude: After correction for difference in body surface area, pre-
